Disease Modifying Genes in Severe Asthma

Gene and protein bank to study disease modifying and susceptibility genes and proteins in urban patients with asthma.

Completed

Looking for future studies?

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

NYU School of Medicine

New York, 10016, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ages 18 and above

Exclusion criteria

Greater than 10 pack year tobacco history
Lung diseases other than asthma

Treatment and study plan

Primary outcomes

To recruit and characterize a cohort of subjects with asthma who reside in a high pollution, high asthma risk neighborhood

Time frame: five yeARS

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Registry information

Important dates

Study start: 2002
Primary completion: 2011
Study completion: 2019
First posted: Sep 21, 2005
Registry last updated: Aug 30, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed